Cite
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.
MLA
Michalski, Jeff M., et al. “Preliminary Toxicity Analysis of 3-Dimensional Conformal Radiation Therapy versus Intensity Modulated Radiation Therapy on the High-Dose Arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial.” International Journal of Radiation Oncology, Biology, Physics, vol. 87, no. 5, Dec. 2013, pp. 932–38. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2013.07.041.
APA
Michalski, J. M., Yan, Y., Watkins-Bruner, D., Bosch, W. R., Winter, K., Galvin, J. M., Bahary, J.-P., Morton, G. C., Parliament, M. B., & Sandler, H. M. (2013). Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. International Journal of Radiation Oncology, Biology, Physics, 87(5), 932–938. https://doi.org/10.1016/j.ijrobp.2013.07.041
Chicago
Michalski, Jeff M, Yan Yan, Deborah Watkins-Bruner, Walter R Bosch, Kathryn Winter, James M Galvin, Jean-Paul Bahary, Gerard C Morton, Matthew B Parliament, and Howard M Sandler. 2013. “Preliminary Toxicity Analysis of 3-Dimensional Conformal Radiation Therapy versus Intensity Modulated Radiation Therapy on the High-Dose Arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial.” International Journal of Radiation Oncology, Biology, Physics 87 (5): 932–38. doi:10.1016/j.ijrobp.2013.07.041.